NVDA
NVIDIA
-- 145.140 PLTR
Palantir
-- 69.850 SMCI
Super Micro Computer
-- 41.810 TSLA
Tesla
-- 357.930 MSTR
MicroStrategy
-- 406.000 
Vcanbio Cell & Gene Engineering's low ROE is offset by impre...
Vcanbio Cell & Gene Engineering's low ROE is offset by impressive earnings growth, potentially leading to long-term stock rise. The company's reinvestment of profits into the business is seen as a positive contributing factor.
Declining Stock and Decent Financials: Is The Market Wrong About Vcanbio Cell & Gene Engineering Corp., Ltd (SHSE:600645)?
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment